EGFR
EGFR (epidermal growth factor receptor) inhibitors are compounds that block the signaling of EGFR, a receptor that is often overexpressed in various cancers and plays a critical role in angiogenesis. EGFR inhibitors are used to prevent tumor growth and metastasis by disrupting the pathways that promote blood vessel formation in tumors. These inhibitors are widely used in cancer research and therapy. At CymitQuimica, we offer a diverse selection of high-quality EGFR inhibitors to support your research in oncology and angiogenesis.
Read more
Barecetamab
CAS:2275727-74-5
Barecetamab (ISU-104) is a humanized monoclonal antibody against tyrosine protein kinase ErbB3 with anticancer activity.
Color and Shape:
Liquid
Ref: TM-T76918
| 1mg | 307.00 € | ||
| 5mg | 990.00 € | ||
| 10mg | 1,335.00 € | ||
| 25mg | 1,979.00 € | ||
| 50mg | 2,669.00 € | ||
| 100mg | 3,602.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EGFR-IN-84
EGFR-IN-84 (Compound 6g), an EGFR inhibitor with an IC50 of 24 nM, impedes the growth …
Formula:
C25H20N6O3S2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
516.59
Ref: TM-T79386
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Nezutatug
CAS:2673271-78-6
Nezutatug, an anti-HER3 antibody, serves as a research tool in cancer studies [1].
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T81679
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
BI-4732
CAS:2769715-68-4
BI-4732 is an EGFR inhibitor with antitumor activity, inhibits EGFR activation, and suppresses T790M mutations.
Formula:
C32H36N10O2
Color and Shape:
Liquid
Molecular weight:
592.69
Ref: TM-T85354
| 1mg | 349.00 € | ||
| 5mg | 776.00 € | ||
| 10mg | 1,041.00 € | ||
| 25mg | 1,547.00 € | ||
| 50mg | 2,091.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Befotertinib
CAS:1835667-63-4
Befotertinib (D-0316) is an inhibitor of EGFR tyrosine kinase and can be used for studies …
Formula:
C29H32F3N7O2
Purity:
99.40%
Color and Shape:
Liquid
Molecular weight:
567.61
Ref: TM-T39275
| 1mg | 87.00 € | ||
| 5mg | 183.00 € | ||
| 10mg | 291.00 € | ||
| 25mg | 513.00 € | ||
| 50mg | 730.00 € | ||
| 100mg | 1,002.00 € | ||
| 1mL*10mM (DMSO) | 230.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EGFR/BRAFV600E-IN-2
E07 Aptamer, targeting the human epidermal growth factor receptor (hEGFR), competes with epidermal growth factor …
Formula:
C25H18N4O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
406.44
Ref: TM-T78849
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EGFR/BRAFV600E-IN-3
EGFR/BRAFV600E-IN-3 is an inhibitor targeting EGFR, BRAFV600E, and EGFRT790M with IC50 values of 57 nM, …
Formula:
C25H18N4O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
422.44
Ref: TM-T78850
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EGFR/CDK2-IN-3
EGFR/CDK2-IN-3 (compound 4b) serves as a dual inhibitor targeting both EGFR and CDK-2, exhibiting IC50 …
Formula:
C30H20N6OS
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
512.58
Ref: TM-T79728
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EGFR/CDK2-IN-2
EGFR/CDK2-IN-2 (compound 6a) serves as a dual inhibitor targeting both EGFR and CDK-2, exhibiting IC50 …
Formula:
C49H32N12O2S2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
884.99
Ref: TM-T79727
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Oritinib
CAS:2035089-28-0
Oritinib (SH-1028) is an inhibitor of EGFR with IC50s of 18, 0.7, 4, 0.1, 1.4 …
Formula:
C31H37N7O2
Purity:
98.4%
Color and Shape:
Soild
Molecular weight:
539.67
Ref: TM-T60076
| 1mg | 131.00 € | ||
| 5mg | 314.00 € | ||
| 10mg | 458.00 € | ||
| 25mg | 759.00 € | ||
| 50mg | 1,012.00 € | ||
| 100mg | 1,383.00 € | ||
| 1mL*10mM (DMSO) | 365.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EGFR/CDK2-IN-4
EGFR/CDK2-IN-4 (compound 4c) is a dual inhibitor targeting EGFR and CDK-2, demonstrating IC50 values of …
Formula:
C24H16N6OS2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
468.55
Ref: TM-T79729
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Cinrebafusp alfa
CAS:2218515-90-1
Cinrebafusp alfa (PRS 343) is an anticalin-based bispecific drug with high affinity for both CD137/HER2, …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80590
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
CH7233163
CH7233163 is a useful organic compound for research related to life sciences and the catalog …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T35334
| 5mg | 317.00 € | ||
| 25mg | 937.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Serclutamab
CAS:2140172-41-2
Serclutamab, a humanized chimeric monoclonal antibody of the IgG1-κ isotype, selectively targets the epidermal growth …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80614
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EGFR/PI3Kα-IN-1
EGFR/PI3Kα-IN-1 (compound 30k), a dual EGFR/PI3Kα inhibitor, exhibits potent activity with IC 50 values of …
Formula:
C50H49N11O5S
Color and Shape:
Liquid
Molecular weight:
916.06
Ref: TM-T200282
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Coprelotamab
CAS:2348469-84-9
Coprelotamab (GB-221) is an IgG-κ monoclonal antibody that targets EGFR2, frequently produced in CHO DG44 …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80596
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
JH-XI-10-02
CAS:2209085-22-1
JH-XI-10-02 selectively degrades CDK8 (IC50: 159 nM) through proteasome, sparing CDK8 mRNA and CDK19.
Formula:
C53H69N5O9
Purity:
98%
Color and Shape:
Solid
Molecular weight:
920.161
Ref: TM-T13743
| 2mg | 1,366.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Tyrosine kinase-IN-7
CAS:345615-74-9
Tyrosine kinase-IN-7 is a potent inhibitor of the tyrosine kinase EGFR, inhibiting EGFR(WT) and EGFR(T790M) …
Formula:
C16H15N3OS
Purity:
99.93%
Color and Shape:
Liquid
Molecular weight:
297.38
Ref: TM-T77746
| 5mg | 35.00 € | ||
| 10mg | 47.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Astragaloside VI
CAS:84687-45-6
Astragaloside VI could improve wound healing by activating the EGFR/ERK signaling pathway.
Formula:
C47H78O19
Purity:
98%
Color and Shape:
Solid
Molecular weight:
947.122
Ref: TM-T13559
| 10mg | 562.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EGFR-IN-76
CAS:2607829-38-7
EGFR-IN-76 is a potent EGFR inhibitor.
Formula:
C30H30ClFN6O2
Purity:
97.02% - 97.72%
Color and Shape:
Liquid
Molecular weight:
561.05
Ref: TM-T75120
| 1mg | 119.00 € | ||
| 5mg | 285.00 € | ||
| 10mg | 452.00 € | ||
| 25mg | 868.00 € | ||
| 50mg | 1,393.00 € | ||
| 100mg | 1,894.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
